Abstract | BACKGROUND: METHODS: We retrospectively collected data about the opioid therapy used for OM-induced pain in all patients with oropharyngeal cancer treated with chemoradiotherapy (CRT) between 2009 and 2013. To compare the different opioids, a conversion into oral morphine equivalent daily dose (OMEDD) was performed. The highest OMEDD (h-OMEDD) and the opioids' weekly increase were associated with patient, tumor, or treatment-related characteristics in order to identify predictive factors of opioid consumption. RESULTS: Ninety-seven percent of patients received opioids. The h-OMEDD was significantly correlated with a higher OM-grade and a lower smoking history. The weekly opioids' increase was higher in patients with lower smoking history and human papillomavirus (HPV) positivity. CONCLUSION:
Opioid therapy remains the mainstay for OM-related pain management during CRT. The role of previous smoking and HPV on opioid use needs further confirmations. © 2016 Wiley Periodicals, Inc. Head Neck 38: E1521-E1527, 2016.
|
Authors | Salvatore Alfieri, Carla I Ripamonti, Sara Marceglia, Ester Orlandi, Nicola A Iacovelli, Roberta Granata, Anna Cavallo, Paolo Pozzi, Roberto Boffi, Cristiana Bergamini, Martina Imbimbo, Laura Pala, Carlo Resteghini, Aurora Mirabile, Laura D Locati, Lisa Licitra, Paolo Bossi |
Journal | Head & neck
(Head Neck)
Vol. 38 Suppl 1
Pg. E1521-7
(04 2016)
ISSN: 1097-0347 [Electronic] United States |
PMID | 26849016
(Publication Type: Journal Article)
|
Copyright | © 2016 Wiley Periodicals, Inc. |
Chemical References |
- Analgesics
- Analgesics, Opioid
|
Topics |
- Adult
- Aged
- Analgesics
(administration & dosage, therapeutic use)
- Analgesics, Opioid
(administration & dosage, therapeutic use)
- Chemoradiotherapy
(adverse effects)
- Female
- Humans
- Male
- Middle Aged
- Mucositis
(chemically induced)
- Oropharyngeal Neoplasms
(therapy)
- Smoking
|